New research shows lung injury and dysregulated macrophages create an environment that supports tuberculosis growth, offering ...
Resolution Therapeutics Limited ("Resolution" or "Company"), a clinical-stage biopharmaceutical company pioneering Regenerative Macrophage Therapy in inflammatory and fibrotic diseases, today ...
Tuberculosis (TB) remains a major global health challenge, affecting more than 10 million people annually worldwide, with ...
Researchers have shown how a type of macrophage protects insulin-producing cells in the pancreas from T cells, preventing ...
EDINBURGH and CAMBRIDGE, United Kingdom, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Macomics Ltd, a leader in macrophage drug discovery, announces that it has validated its ENIGMAC™ platform in ...
Resolution Therapeutics Ltd ("Resolution" or "Company"), a clinical-stage biopharmaceutical company pioneering Regenerative Macrophage Therapy (RMT) in inflammatory and fibrotic diseases, today ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window In a small ...
Macrophages rely on lysosomes to balance microbial killing with self-protection, generating reactive oxygen and nitrogen ...
Emapalumab-lzsg is a monoclonal antibody that binds to and neutralizes interferon gamma, a key cytokine in the development of MAS. The Food and Drug Administration (FDA) has granted Fast Track ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback